News & Perspective

Jan 17, 2007

Jan 17, 2007

HHS funds work on dose-sparing H5N1 vaccines

(CIDRAP News) – In an effort to stretch the nation's supply of vaccines for a potential influenza pandemic, federal health officials today announced contracts totaling $132.5 million to help three companies develop dose-sparing substances, or adjuvants, to be used with H5N1 flu vaccines.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 30, 2007

Oct 30, 2007

THE PANDEMIC VACCINE PUZZLE Part 4: The promise and problems of adjuvants

Editor's note: This is the fourth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jan 23, 2008

Jan 23, 2008

GAO cites barriers to antiviral, vaccine roles in pandemic

(CIDRAP News) – Antiviral medications and vaccines are two tools that many government and health officials hope will stall the spread of an influenza pandemic, but each strategy has daunting challenges, according to a new report from Congress's Government Accountability Office (GAO).

May 06, 2009

May 06, 2009

FDA approves new vaccine facility

(CIDRAP News) –The US Food and Drug Administration (FDA) today announced approval of a new influenza vaccine manufacturing facility in Pennsylvania that could be used to produce a vaccine against the novel influenza H1N1 (swine flu) virus.

Jun 17, 2014

Jun 17, 2014

Flu Scan for Jun 17, 2014

H7N9 in China
Low global flu activity
Recombinant flu vaccine contract

Mar 10, 2015

Mar 10, 2015

Flu Scan for Mar 10, 2015

More queries on flu vaccine mismatch
Global flu activity

Jan 19, 2018

Jan 19, 2018

News Scan for Jan 19, 2018

HHS government shutdown plan
Saudi MERS
Mutated flu virus for vaccine
Yellow fever in Brazil
Polio in Afghanistan

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»